H1B Report
Side-by-side comparison

APPCO Pharma LLC vs COGNIZANT TECHNOLOGY SOLUTIONS US CORP

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
APPCO Pharma LLC
NJRank #FEIN 47-2145170
Entity B
COGNIZANT TECHNOLOGY SOLUTIONS US CORP
TXRank #2FEIN 13-3924155

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricAPPCO Pharma LLCCOGNIZANT TECHNOLOGY SOLUTIONS US CORP
Total filings261128,852
Certified %92.72%96.13%
Denied %0.00%0.28%
Withdrawn %6.13%2.23%
Cert-withdrawn %1.15%1.36%
Rank#2
Active yearsFY2013–FY2025FY2010–FY2026
Worksite stateNJTX

Outcomes — APPCO Pharma LLC

DOL case-status mix.

Outcome breakdown: Certified 92.7%, Cert-withdrawn 1.1%, Withdrawn 6.1%
Outcome breakdown
OutcomeShare
Certified92.7%
Cert-withdrawn1.1%
Withdrawn6.1%
Certified92.7%
Cert-withdrawn1.1%
Withdrawn6.1%

Outcomes — COGNIZANT TECHNOLOGY SOLUTIONS US CORP

DOL case-status mix.

Outcome breakdown: Certified 96.1%, Cert-withdrawn 1.4%, Withdrawn 2.2%, Denied 0.3%
Outcome breakdown
OutcomeShare
Certified96.1%
Cert-withdrawn1.4%
Withdrawn2.2%
Denied0.3%
Certified96.1%
Cert-withdrawn1.4%
Withdrawn2.2%
Denied0.3%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

APPCO Pharma LLC
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20100
FY20110
FY20120
FY201338
FY201414
FY201536
FY201641
FY201730
FY201828
FY201918
FY20205
FY20210
FY20228
FY20232
FY202431
FY202510
FY20260
COGNIZANT TECHNOLOGY SOLUTIONS US CORP
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20101,476
FY20112,735
FY20121,772
FY20131,557
FY20142,189
FY20153,112
FY20164,612
FY20172,384
FY201812,460
FY201925,569
FY20203,117
FY202110,079
FY202213,705
FY202315,729
FY202411,437
FY202511,140
FY20265,779

Top 5 occupations — APPCO Pharma LLC

Top 5 occupations — COGNIZANT TECHNOLOGY SOLUTIONS US CORP

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.